MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
2.100
-0.004
-0.19%
After Hours: 2.130 +0.03 +1.43% 18:42 09/11 EDT
OPEN
2.190
PREV CLOSE
2.104
HIGH
2.190
LOW
2.050
VOLUME
36.76K
TURNOVER
--
52 WEEK HIGH
15.15
52 WEEK LOW
2.050
MARKET CAP
3.68M
P/E (TTM)
-0.3937
1D
5D
1M
3M
1Y
5Y
1D
Silo Pharma To Highlight SPC-15 Nose-To-Brain Technology At 2026 Nasal Innovation Forum
NASDAQ · 2d ago
Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
Barchart · 2d ago
Weekly Report: what happened at SILO last week (0831-0904)?
Weekly Report · 4d ago
Weekly Report: what happened at SILO last week (0824-0828)?
Weekly Report · 08/31 09:40
Weekly Report: what happened at SILO last week (0817-0821)?
Weekly Report · 08/24 09:40
Psychedelic: Enveric, Helus, Bright Minds report earnings results
TipRanks · 08/20 15:30
Silo Pharma Acquires Digital Assets via Stock Issuance
TipRanks · 08/19 21:51
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting On August 18, 2026; Issues 165,000 Shares As Consideration For Asset Purchase
Benzinga · 08/19 21:21
More
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.